Original ArticleThe ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish studyEl ART-SCORE no es una herramienta eficaz para optimizar la selección de pacientes para el tratamiento con DEB-TACE. Estudio multicéntrico español

Maria Pipa Muniz,Lluis Castells,Sonia Pascual,Javier Fernández-Castroagudín,Iratxe Díez Miranda,Javier Irurzun,Roberto Díaz Beveridge,María Senosiaín,Juan Arenas,Manuel de la Mata,Juan Turnes,María Isabel Monge-Romero,Daniel Pérez-Enguix,Javier Bustamante Schneider,Nora Otegui,Esther Molina-Pérez,Jose-Eduardo Rodriguez Menendez,M. Varela

Original ArticleThe ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish studyEl ART-SCORE no es una herramienta eficaz para optimizar la selección de pacientes para el tratamiento con DEB-TACE. Estudio multicéntrico español

2017

Maria Pipa Muniz
Lluis Castells
Sonia Pascual
Javier Fernández-Castroagudín
Iratxe Díez Miranda
Javier Irurzun
Roberto Díaz Beveridge
María Senosiaín
Juan Arenas
Manuel de la Mata
Juan Turnes
María Isabel Monge-Romero
Daniel Pérez-Enguix
Javier Bustamante Schneider
Nora Otegui
Esther Molina-Pérez
Jose-Eduardo Rodriguez Menendez
M. Varela

Introduction The appropriate selection of hepatocellular carcinoma (HCC) patients who are eligible for transarterial chemoembolization (TACE) remains a challenge. The ART score has recently been proposed as a method of identifying patients who are eligible or not for a second TACE procedure.

Keywords:

Pathology
Oncology
Hepatocellular carcinoma
Medicine
Survival rate
Internal medicine
Retrospective cohort study
Gastroenterology
liver neoplasm
deb tace

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations